I recommend these to everyone.
Interventions: CagriSema (Cagrilintide B and Semaglutide I), placebo Primary Outcome Measure: Relative change in body weight Time Frame: From baseline (week 0) to week 80 Study Details Source VK2735 for Weight Management Phase 3 (VANQUISH 1) Sponsor: Viking Therapeutics Goal: This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI 30 kg/m2) or overweight (BMI 27 kg/m2) with one or more weight related comorbid condition without Type 2 Diabetes
You should hold the syringe at eye level to ensure you are reading the volume correctly at the bottom of the meniscus (the curve of the liquid)
Certain laser and light-based treatments, such as photodynamic therapy (PDT) and intense pulsed light (IPL), can target acne-causing bacteria and reduce sebum production
statins are safe and should be used according to cardiovascular risk assessment Patients taking metformin should not discontinue this important diabetes medication but should ensure adequate B12 monitoring as advised by the MHRA
